NeoDynamics AB is a medical technology company, which engages in the development of the diagnosis and treatment of breast cancer. It offers a biopsy system, NeoNavia, which utilizes a patented micro-pulse technology designed to offer accurate tissue sampling with a large exchange of tissue. The company was founded by Hans Wiksell and Gert Auer in 2004 and is headquartered in Lidingö, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company